U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
December 7, 2023 Comments Off
The U.S. Food and Drug Administration is expected to approve exa-cel for sickle cell disease in what would become the first marketed medicine to use CRISPR.
U.S. poised to approve first gene-editing treatment in breakthrough for sickle cell patients
The U.S. Food and Drug Administration is expected to approve exa-cel for sickle cell disease in what would become the first marketed medicine to use CRISPR.
Archives
Categories
Archives
Recent Posts
Meta
Categories
Calender